SAS Output

25-APR-2019 6:10

LUNG ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1400-SCCA,Adv, Biomarker Master 1 N 1 Specimen Submission   1864 258 48 4 0 0 07/08/2014 449 205
            1864 258 48 4 0 0      
 
    2 Y 17 S1400G   61 7 0 0 0 0      
        2 S1400A   160 0 0 0 0 0 07/08/2014    
        21 S1400F   152 105 44 15 9 1      
        25 S1400K   50 29 0 0 0 0      
        3 S1400B   53 0 0 0 0 0      
        30 S1900A   6 6 6 6 2 1      
        4 S1400C   88 0 0 0 0 0      
        5 S1400D   92 0 0 0 0 0      
        6 S1400E   16 0 0 0 0 0      
        7 S1400I   699 0 0 0 0 0      
            1377 147 50 21 11 2      
 
    3 P 10 S1400I   13 0 0 0 0 0      
        18 S1400G   10 0 0 0 0 0      
        22 S1400F   26 14 2 1 1 0      
        32 S1900A   3 3 3 3 0 0      
        8 S1400B   1 0 0 0 0 0 07/08/2014    
            53 17 5 4 1 0      
 
    4 P 23 S1400F   3 1 0 0 0 0 07/08/2014    
            3 1 0 0 0 0      
 
  S1400F-Non-Match: MEDI4736 + Tremelimumab 1 Y 1 MEDI4736 + Tremelimumab 132 61 44 21 7 2 0 11/30/2017 449 205
            61 44 21 7 2 0      
 
  S1619-Meso,Stg I-III, Nadj chemo/Atezmb->Atezmb+SOC 1 Y 1 Chemotherapy + Atezolizumab 28 14 14 9 6 2 1 07/16/2018 85 28
            14 14 9 6 2 1      
 
    2 Y 2 Surgery 28 6 6 6 3 2 0 07/16/2018    
            6 6 6 3 2 0      
 
    3 Y 3 Maintenance 28 5 5 5 4 2 0 07/16/2018    
            5 5 5 4 2 0      
 
  S1701-Thymic Adv, Carbo/Pac/Ram vs. Carbo/Pac 1 Y 1 Ramucirumab + Carbo/Paclitaxel 66 1 1 1 1 0 0 03/20/2019 94 31
            1 1 1 1 0 0      
 
  S1900A-LOH and/or BRCA: Rucaparib 1 Y 1 Rucaparib 88 1 1 1 1 1 0 04/16/2019 165 68
            1 1 1 1 1 0      
 
  LUNGMAP-NSCLC, Adv, Master 0 Y 0 ctDNA Specimen Submission   24 24 24 24 10 0 02/06/2019 274 129
            24 24 24 24 10 0      
 
    1 Y 1 Tissue Submission   132 132 132 132 60 5 02/06/2019    
            132 132 132 132 60 5      
 
    2 Y 2 S1400F   8 8 8 8 1 0 02/06/2019    
        5 S1900A   4 4 4 4 3 0      
            12 12 12 12 4 0      
 
Yes A081105-ALCHEMIST1, EGFR mut, Erlotinib 1 E Total Registrations   54 16 12 7 2 1 04/01/2015 491 251
            54 16 12 7 2 1      
 
  A151216-ALCHEMIST0 - screening 1 E Total Registrations   695 204 89 44 15 0 12/16/2014 485 251
            695 204 89 44 15 0      
 
  C30610-SCLC, Thoracic RT 1 E Total Registrations   57 2 1 1 0 0 05/14/2008 156 85
            57 2 1 1 0 0      
 
  E4512-ALCHEMIST2, ALK mut, Crizotinib 1 E Total Registrations   12 5 2 0 0 0 02/29/2016 375 215
            12 5 2 0 0 0      
 
  NRGCC003-SCLC, PCI or HA-PCI 1 E Total Registrations   4 0 0 0 0 0 10/20/2016 237 121
            4 0 0 0 0 0      
 
    2 E Total Registrations   4 0 0 0 0 0 10/20/2016    
            4 0 0 0 0 0      
 
No A151216-ALCHEMIST0 - screening 0 E Total Registrations   708 211 91 48 17 0 12/16/2014 485 251
            708 211 91 48 17 0      
 
  EA5142-ALCHEMIST3, Non-match, Nivolumab 1 E Total Registrations   102 59 27 16 5 2 08/03/2016 460 246
            102 59 27 16 5 2      
 

25-APR-2019 6:10

LUNG Open Studies with No Registrations

The REPORT Procedure

Detailed and/or summarized report

Table 1

Study Registration/Phase Open Date
LUNGMAP NSCLC, Adv, Master 3 Sub-study Assignment II 28-Jan-19
  4 Sub-study Assignment III 28-Jan-19
  5 Sub-study Assignment IV 28-Jan-19